Position in GSK
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$203,816
New position
Shares Held
3,693
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bulltick Wealth Management, LLC holds $5,539,170 across 8 Drug Manufacturers - General names. GSK ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
86,030 | $3,161,602 | |
| 2 | PFE |
Pfizer Inc
|
22,859 | $641,880 | |
| 3 | ABBV |
AbbVie Inc.
|
1,721 | $374,300 | |
| 4 | LLY |
ELI LILLY & Co
|
364 | $334,796 | |
| 5 | SNY |
Sanofi
|
6,818 | $328,491 | |
| 6 | JNJ |
Johnson & Johnson
|
1,334 | $326,082 | |
| 7 | GSK |
GSK plc
This page
|
3,693 | $203,816 | |
| 8 | GRFS |
Grifols SA
|
20,973 | $168,203 |
All Filings in GSK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $203,816 | 3,693 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||